The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Delivery Technologies-Global Market Insights and Sales Trends 2024
Synopsis
The global Drug Delivery Technologies market size is expected to reach US$ 1133150 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Delivery Technologies in various end use industries. The expanding demands from the Hospitals, Home Care Settings, Clinics and Diagnostic Centres, are propelling Drug Delivery Technologies market. Oral Drug Delivery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pulmonary Drug Delivery segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Delivery Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Delivery Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Delivery Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Delivery Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Delivery Technologies covered in this report include Johnson & Johnson Services, Novartis, Roche, Pfizer, Bayer, Antares Pharma, Becton Dickinson, GlaxoSmithKline and Kindeva, etc.
The global Drug Delivery Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson Services
Novartis
Roche
Pfizer
Bayer
Antares Pharma
Becton Dickinson
GlaxoSmithKline
Kindeva
Merck
Sanofi
Global Drug Delivery Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Delivery Technologies market, Segment by Type:
Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Global Drug Delivery Technologies market, by Application
Hospitals
Home Care Settings
Clinics
Diagnostic Centres
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Delivery Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Drug Delivery Technologies market size is expected to reach US$ 1133150 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Delivery Technologies in various end use industries. The expanding demands from the Hospitals, Home Care Settings, Clinics and Diagnostic Centres, are propelling Drug Delivery Technologies market. Oral Drug Delivery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pulmonary Drug Delivery segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Delivery Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Delivery Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Delivery Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Delivery Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Delivery Technologies covered in this report include Johnson & Johnson Services, Novartis, Roche, Pfizer, Bayer, Antares Pharma, Becton Dickinson, GlaxoSmithKline and Kindeva, etc.
The global Drug Delivery Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson Services
Novartis
Roche
Pfizer
Bayer
Antares Pharma
Becton Dickinson
GlaxoSmithKline
Kindeva
Merck
Sanofi
Global Drug Delivery Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Delivery Technologies market, Segment by Type:
Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Global Drug Delivery Technologies market, by Application
Hospitals
Home Care Settings
Clinics
Diagnostic Centres
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Delivery Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drug Delivery Technologies
1.1 Drug Delivery Technologies Market Overview
1.1.1 Drug Delivery Technologies Product Scope
1.1.2 Drug Delivery Technologies Market Status and Outlook
1.2 Global Drug Delivery Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Delivery Technologies Market Size by Region (2018-2029)
1.4 Global Drug Delivery Technologies Historic Market Size by Region (2018-2023)
1.5 Global Drug Delivery Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Delivery Technologies Market Size (2018-2029)
1.6.1 North America Drug Delivery Technologies Market Size (2018-2029)
1.6.2 Europe Drug Delivery Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Delivery Technologies Market Size (2018-2029)
1.6.4 Latin America Drug Delivery Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Delivery Technologies Market Size (2018-2029)
2 Drug Delivery Technologies Market by Type
2.1 Introduction
2.1.1 Oral Drug Delivery
2.1.2 Pulmonary Drug Delivery
2.1.3 Injectable Drug Delivery
2.1.4 Ocular Drug Delivery
2.1.5 Nasal Drug Delivery
2.1.6 Topical Drug Delivery
2.1.7 Implantable Drug Delivery
2.1.8 Transmucosal Drug Delivery
2.2 Global Drug Delivery Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Delivery Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Delivery Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Delivery Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Delivery Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Delivery Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Delivery Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Delivery Technologies Revenue Breakdown by Type (2018-2029)
3 Drug Delivery Technologies Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Home Care Settings
3.1.3 Clinics
3.1.4 Diagnostic Centres
3.1.5 Other
3.2 Global Drug Delivery Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Delivery Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Delivery Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Delivery Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Delivery Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Delivery Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Delivery Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Delivery Technologies Revenue Breakdown by Application (2018-2029)
4 Drug Delivery Technologies Competition Analysis by Players
4.1 Global Drug Delivery Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Delivery Technologies as of 2022)
4.3 Date of Key Players Enter into Drug Delivery Technologies Market
4.4 Global Top Players Drug Delivery Technologies Headquarters and Area Served
4.5 Key Players Drug Delivery Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Delivery Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson Services
5.1.1 Johnson & Johnson Services Profile
5.1.2 Johnson & Johnson Services Main Business
5.1.3 Johnson & Johnson Services Drug Delivery Technologies Products, Services and Solutions
5.1.4 Johnson & Johnson Services Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Services Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Drug Delivery Technologies Products, Services and Solutions
5.2.4 Novartis Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Drug Delivery Technologies Products, Services and Solutions
5.3.4 Roche Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Drug Delivery Technologies Products, Services and Solutions
5.4.4 Pfizer Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business
5.5.3 Bayer Drug Delivery Technologies Products, Services and Solutions
5.5.4 Bayer Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Recent Developments
5.6 Antares Pharma
5.6.1 Antares Pharma Profile
5.6.2 Antares Pharma Main Business
5.6.3 Antares Pharma Drug Delivery Technologies Products, Services and Solutions
5.6.4 Antares Pharma Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 Antares Pharma Recent Developments
5.7 Becton Dickinson
5.7.1 Becton Dickinson Profile
5.7.2 Becton Dickinson Main Business
5.7.3 Becton Dickinson Drug Delivery Technologies Products, Services and Solutions
5.7.4 Becton Dickinson Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 Becton Dickinson Recent Developments
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Profile
5.8.2 GlaxoSmithKline Main Business
5.8.3 GlaxoSmithKline Drug Delivery Technologies Products, Services and Solutions
5.8.4 GlaxoSmithKline Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 GlaxoSmithKline Recent Developments
5.9 Kindeva
5.9.1 Kindeva Profile
5.9.2 Kindeva Main Business
5.9.3 Kindeva Drug Delivery Technologies Products, Services and Solutions
5.9.4 Kindeva Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 Kindeva Recent Developments
5.10 Merck
5.10.1 Merck Profile
5.10.2 Merck Main Business
5.10.3 Merck Drug Delivery Technologies Products, Services and Solutions
5.10.4 Merck Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.10.5 Merck Recent Developments
5.11 Sanofi
5.11.1 Sanofi Profile
5.11.2 Sanofi Main Business
5.11.3 Sanofi Drug Delivery Technologies Products, Services and Solutions
5.11.4 Sanofi Drug Delivery Technologies Revenue (US$ Million) & (2018-2023)
5.11.5 Sanofi Recent Developments
6 North America
6.1 North America Drug Delivery Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Delivery Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Delivery Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Delivery Technologies Market Dynamics
11.1 Drug Delivery Technologies Industry Trends
11.2 Drug Delivery Technologies Market Drivers
11.3 Drug Delivery Technologies Market Challenges
11.4 Drug Delivery Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
